Discover how scientists are using CRISPR-loaded extracellular vesicles as Trojan horses to target and destroy osteosarcoma bone cancer cells with precision.
Discover how targeting the E3 ubiquitin ligase CBL offers promising new approaches to fight osteosarcoma by reprogramming cellular recycling systems.
Discover how the long non-coding RNA A1BG-AS1 promotes osteosarcoma progression through molecular mechanisms and potential therapeutic targets.
How dual-functional nanoplatforms are transforming osteosarcoma treatment by modulating the tumor microenvironment and activating immune responses.
Discover how hypoxia-induced WSB1 protein drives osteosarcoma metastasis and the potential therapeutic strategies targeting this pathway.